Abstract
Retroviral short hairpin RNA (shRNA)-mediated genetic screens in mammalian cells are powerful tools for discovering loss-of-function phenotypes. We describe a highly parallel multiplex methodology for screening large pools of shRNAs using half-hairpin barcodes for microarray deconvolution. We carried out dropout screens for shRNAs that affect cell proliferation and viability in cancer cells and normal cells. We identified many shRNAs to be antiproliferative that target core cellular processes, such as the cell cycle and protein translation, in all cells examined. Moreover, we identified genes that are selectively required for proliferation and survival in different cell lines. Our platform enables rapid and cost-effective genome-wide screens to identify cancer proliferation and survival genes for target discovery. Such efforts are complementary to the Cancer Genome Atlas and provide an alternative functional view of cancer cells.
MeSH Terms
Breast Neoplasms/genetics,pathology
Cell Line
Cell Line, Tumor
Cell Proliferation
Cell Survival/genetics
Colonic Neoplasms/genetics,pathology
Gene Library
Genes, Neoplasm
Genetic Vectors
Genome, Human
Genomics/methods
Humans
MicroRNAs
Oligonucleotide Array Sequence Analysis
RNA, Small Interfering
Retroviridae/genetics
Chemicals
MicroRNAs
RNA, Small Interfering
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Schlabach Michael R
Howard Hughes Medical Institute and Department of Genetics, Center for Genetics and Genomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Luo Ji
Solimini Nicole L
Hu Guang
Xu Qikai
Li Mamie Z
Zhao Zhenming
Smogorzewska Agata
Sowa Mathew E
Ang Xiaolu L
Westbrook Thomas F
Liang Anthony C
Chang Kenneth
Hackett Jennifer A
Harper J Wade
Hannon Gregory J
Elledge Stephen J
References (18)
18 references, click to expand
-
A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
Nature. 2004 Mar 25;428(6981):431-7
PMID: 15042092
-
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Science. 2004 Feb 6;303(5659):844-8
PMID: 14704432
-
A genetic screen for candidate tumor suppressors identifies REST.
Cell. 2005 Jun 17;121(6):837-48
PMID: 15960972
-
A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.
Cell. 2005 Jun 17;121(6):849-58
PMID: 15960973
-
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.
Nat Genet. 2005 Nov;37(11):1289-95
PMID: 16200064
-
A loss-of-function RNA interference screen for molecular targets in cancer.
Nature. 2006 May 4;441(7089):106-10
PMID: 16572121
-
A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling.
Nat Cell Biol. 2007 May;9(5):556-64
PMID: 17417629
-
The ubiquitin-specific protease USP28 is required for MYC stability.
Nat Cell Biol. 2007 Jul;9(7):765-74
PMID: 17558397
-
A resource for large-scale RNA-interference-based screens in mammals.
Nature. 2004 Mar 25;428(6981):427-31
PMID: 15042091
-
Non-oncogene addiction and the stress phenotype of cancer cells.
Cell. 2007 Sep 21;130(6):986-8
PMID: 17889643
-
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors.
Nat Chem Biol. 2006 Apr;2(4):202-6
PMID: 16474381
-
Second-generation shRNA libraries covering the mouse and human genomes.
Nat Genet. 2005 Nov;37(11):1281-8
PMID: 16200065
-
The consensus coding sequences of human breast and colorectal cancers.
Science. 2006 Oct 13;314(5797):268-74
PMID: 16959974
-
Myosin phosphatase: structure, regulation and function.
Mol Cell Biochem. 2004 Apr;259(1-2):197-209
PMID: 15124925
-
Profiling essential genes in human mammary cells by multiplex RNAi screening.
Science. 2008 Feb 1;319(5863):617-20
PMID: 18239125
-
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.
Nature. 2006 Aug 3;442(7102):576-9
PMID: 16885985
-
The genomic landscapes of human breast and colorectal cancers.
Science. 2007 Nov 16;318(5853):1108-13
PMID: 17932254
-
Normalization of cDNA microarray data.
Methods. 2003 Dec;31(4):265-73
PMID: 14597310